Mesothelioma Immunotherapy 2026: Opdivo, Keytruda & Latest Breakthroughs
📅 Updated: April 2026 | ⏱ 14-minute read | ✅ Medically & Legally Reviewed Introduction In October 2020, the FDA approved nivolumab + ipilimumab (Opdivo + Yervoy) for mesothelioma, the first new treatment approval for this disease in 16 years. It was not a modest advance. The CheckMate 743 trial that supported that approval showed … Read more